Business Wire - Teva Announces Settlement of Litigation with GSK on Nabumetone
April 30, 2003 -- Business Editors/Health/Medical Writers JERUSALEM--(BUSINESS WIRE)--April 30, 2003 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced...
Business Wire - Eon Labs Begins Shipping Nabumetone Tablets
February 26, 2002 -- Business Editors NEW YORK--(BUSINESS WIRE)--February 26, 2002 Eon Labs, Inc. began shipping Nabumetone 500mg and 750mg tablets, the FDA approved...
Bandolier - Nabumetone & meloxicam gastrointestinal safety
June 1, 2000 -- The increasing focus on serious gastrointestinal adverse effects of NSAIDs is resulting in more information becoming available. Two new meta-analyses...
Business Wire - Teva Wins Nabumetone Lawsuit; Will Commence Sales of Generic Equivalent of Relafen Immediately
August 14, 2001 -- Business Editors JERUSALEM--(BUSINESS WIRE)--Aug. 14, 2001 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has won the...
Chemical Market Reporter - NABUMETONE.(Teva Pharmaceutical Industries Ltd.)(Brief Article)(Statistical Data Included)
June 5, 2000 -- Teva Pharmaceutical Industries Ltd. has received final FDA approval to manufacture and market nabumetone 500 mg tablets, the generic version of...
Business Wire - Law Firm Miller Faucher and Cafferty LLP Announce Proposed Class Action Settlement Involving the Drug Relafen
February 16, 2005 -- CHICAGO -- The following was released today by Miller Faucher and Cafferty LLP: The Law firms of: Miller Faucher and Cafferty LLPMilberg Weiss...
Photochemistry and Photobiology - Characterization of the transient intermediates generated from the photoexcitation of nabumetone: A comparison with naproxen
November 1, 1998 -- Lydia J. Martinez* and J. C. Scaiano ABSTRACT The photochemical and photophysical properties of nabumetone (4-[6-methoxy-2-naphthyl]-2-butanone)...
Photochemistry and Photobiology - A photophysical and photochemical study of 6-methoxy-2naphthylacetic acid, the major metabolite of the phototoxic nonsteroidal antiinflammatory drug nabumetone
February 1, 2000 -- ABSTRACT Nabumetone is a phototoxic nonsteroidal antiinflammatory drug used for the treatment of osteoarthritis. However, nabumetone is considered a...
HR Magazine - Summary notice of pending class action
April 1, 2004 -- UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS IN RE RELAFEN ANTITRUST LITIGATION MASTER FILE NO. 01-12239 WGY If you purchased the...
National Underwriter Life & Health-Financial Services Edition - Summary notice of pending class action.(Advertisement)
March 22, 2004 -- If you purchased the brand-name drug Relafen or its generic alternatives (known as nabumetone) in the states of Arizona, California, Massachusetts,...
